首页|Design and synthesis of tri-substituted pyrimidine derivatives as bifunctional tumor immunotherapeutic agents targeting both A2A adenosine receptors and histone deacetylases
Design and synthesis of tri-substituted pyrimidine derivatives as bifunctional tumor immunotherapeutic agents targeting both A2A adenosine receptors and histone deacetylases
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
万方数据
维普
The A2A adenosine receptor(A2AAR)has attracted attention as an emerging immunotherapeutic tar-get with several antagonists being evaluated in clinical trials.However,A2AAR antagonists show lim-ited efficacy as monotherapies.Herein,we communicate our design and synthesis of a novel series of A2AAR/histone deacetylase(HDAC)bifunctional inhibitors,based on the core structure of the A2AAR antag-onist PBF-509 The new compounds were designed using a pharmacophore-merging strategy and features a tri-substituted pyrimidine core.The binding affinity for A2AAR and inhibitory activity against HDACs of all the new compounds were tested.A number of compounds exhibited nanomolar or subnanomo-lar activity against both targets and some showed equally potent antiproliferative activity against MC38,CT26 and HCT116 colon cancer lines compared to HDAC inhibitors SAHA and MGCD-0103 in vitro.The binding poses of compound 5a in both A2AAR and HDAC1 were predicted by molecular docking stud-ies.Collectively,these results suggest these tri-substituted pyrimidine derivatives are promising leads for developing A2AAR/HDAC dual-acting compounds as novel antitumor agents.
NETL
NSTL
万方数据
维普
